Clinical Trials | July 13, 2022
SRL Diagnostics launches fatty liver index
An algorithm based testing for Fatty Liver Disease
An algorithm based testing for Fatty Liver Disease
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The AICVD tool can predict the risk of cardiovascular disease.
Younger Indians have a 10 times higher rate of heart attack
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
LoveDepot.com addresses this gap that is yawning in the market
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Subscribe To Our Newsletter & Stay Updated
